Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis Post author:Sam Post published:October 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Can-Fite BioPharma Reports First Quarter 2017 Financial Results & Provides Clinical Update May 29, 2017 Celgene Co-Founder Bags $23M for Johns Hopkins Spinout NexImmune January 1, 2018 Groundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug July 10, 2017
Can-Fite BioPharma Reports First Quarter 2017 Financial Results & Provides Clinical Update May 29, 2017